1178614

David R. Lally, M.D. — FEI 3023213062

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 5, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Springfield, MA (United States)

Additional Details

Clinical Investigator (CI)